Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.
Clinical trial NCT06356922 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06356922
- Sponsor
- Nantes University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2027-10-22
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.